All Stories

  1. Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?

    Article • Expert Review of Anti-infective Therapy, February 2019, Taylor & Francis

    Suzanne Parker, KOSTOULA ARVANITI